HB 172 New Hampshire House · 2023 Regular Session

relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Bill status died 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 3, 2023 Last action Nov 16, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
11
Key actions
5
Committee
6
Nov 16, 2023
Committee
Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC)
lower
Sep 6, 2023
Lower · Passed
==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36
lower
Aug 30, 2023
Lower · Passed
==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304
lower
Mar 13, 2023
Lower · Passed
Retained in Committee
lower
Feb 23, 2023
Lower · Passed
Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304
lower
Feb 1, 2023
Lower · Passed
Subcommittee Work Session: 02/08/2023 10:45 am LOB 302-304
lower
Jan 3, 2023
Introduced
Introduced 01/04/2023 and referred to Commerce and Consumer Affairs
lower
1 primary · 1 co-sponsor

Sponsors